Skip to main content
Log in

Neuerungen der WHO‑Klassifikation der Hirntumore von 2016

Alterations in the WHO classification of brain tumors from 2016

  • Leitthema
  • Published:
Der Radiologe Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Die Weltgesundheitsorganisation erstellt einheitliche Definitionen und Klassifikationen von Tumoren der verschiedenen Organsysteme.

Fragestellung

Welche Änderungen ergeben sich aus der Fortschreibung der Klassifikation der Hirntumore von 2016?

Material und Methoden

Darstellung der Veränderungen bei Definition und Klassifikation der Hirntumoren in der aktuellen Fortschreibung der WHO, die sich insbesondere durch molekularpathologische Erkenntnisse der letzten Jahre ergeben.

Ergebnisse

Die aktuelle WHO-Klassifikation der Hirntumore basiert erstmals nicht mehr ausschließlich auf histologischen Charakteristika, sondern bezieht molekularpathologische Informationen in Diagnose und Klassifikation etlicher Hirntumore mit ein. Dieses gilt insbesondere für gliale Tumore, Medulloblastome und weitere embryonale Tumore.

Schlussfolgerung

Definition und Klassifikation der Hirntumore entwickeln sich in Richtung einer modularen Diagnostik, bei der histologische und molekularpathologische Informationen in eine Gesamtbewertung einfließen. Ziel ist es, dadurch zu einheitlicheren Diagnosegruppen hinsichtlich Prognose und Therapie zu kommen.

Abstract

Background

The World Health Organization (WHO) provides uniform definitions and a uniform nomenclature for tumors of various organs.

Objective

What changes resulted from the 2016 WHO classification of tumors of the central nervous system?

Material and methods

Changes in the definition and classification of brain tumors of the revised WHO classification are presented. Most changes evolve from the results of molecular pathology that were generated during the last decade.

Results

For the first time the WHO classification of brain tumors is not based exclusively on histology. Molecular parameters add to the definition of a number of tumor entities. Especially the chapters of gliomas, medulloblastomas and other embryonal tumors have been restructured.

Conclusion

Advances in molecular pathology require a modular diagnostics scheme that integrates histological and molecular parameters into a final diagnosis. This approach will result in more precise tumor groups with respect to prognosis and therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Alexandrescu S, Korshunov A, Lai SH et al (2015) Epithelial glioblastomas and anaplastic epitheloid pleomorphic xanthoastrocytomas – same entity or first cousins? Brain Pathol 26:215–223

    Article  PubMed  Google Scholar 

  2. Daumas-Duport C, Scheithauer B, O’Fallon J et al (1988) Grading of astrocytomas. A simple and reproducible method. Cancer 62:2152–2165

    Article  CAS  PubMed  Google Scholar 

  3. Ellison DW, Dalton J, Koczak M et al (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT and non-SHH/WNT molecular subgroups. Acta Neuropathol 121:381–396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hartmann C, Hentschel B, Wick W et al (2010) Patients with IDH1 wild type anaplastic astrocytoma exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognosis effect of higher age: implications for classification of gliomas. Acta Neuropathol 120:707–718

    Article  PubMed  Google Scholar 

  5. Herrlinger U, Jones DTW, Glas M et al (2016) Gliomatosis cerebri: no evidence for a separate brain tumor entity. Acta Neuropathol 131:309–319

    Article  CAS  PubMed  Google Scholar 

  6. Ida CM, Rodriguez FJ, Burger PC et al (2015) Pleomorphic xanthoastrocytoma: natural history and long-term follow-up. Brain Pathol 25:575–586

    Article  CAS  PubMed  Google Scholar 

  7. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumors of the central nervous system. Springer, Berlin, Heidelberg, New York

    Book  Google Scholar 

  8. Kleihues P, Cavenee WK (2000) Pathology and genetics of tumors of the nervous system. IARC Press; International Agency for Research on Cancer, Lyon

    Google Scholar 

  9. Louis DN (2007) WHO classification of tumors of the central nervous system. IARC Press; International Agency for Research on Cancer, Lyon

    Google Scholar 

  10. Louis DN, Ohgaki H, Wiestler OD et al (2016) WHO classification and grading of tumors of the central nervous system. IARC Press; International Agency for Research on Cancer, Lyon

    Google Scholar 

  11. Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820

    Article  PubMed  Google Scholar 

  12. Nobusawa S, Watanabe T, Kleihues P (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15:6002–6007

    Article  CAS  PubMed  Google Scholar 

  13. Ohgaki H, Kleihus P (2013) The definition of primary and secondary glioblastoma. Clin Cancer Res 19:764–772

    Article  CAS  PubMed  Google Scholar 

  14. Pajtler KW, Witt H, Sill M et al (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades and age groups. Cancer Cell 27:728–743

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Parker M, Mohankumar KM, Punchihewa C et al (2014) C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma. Nature 506:451–455

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Perry A, Stafford SL, Scheithauer BW et al (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455–1465

    Article  CAS  PubMed  Google Scholar 

  17. Rodriguez FJ, Schneiderjan MJ, Nicolaides T et al (2015) High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms. Acta Neuropathol 129(5):609–610

    Article  PubMed  PubMed Central  Google Scholar 

  18. Rutkowski S, von Hoff K, Emser A (2010) Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol 28:4961–4968

    Article  PubMed  Google Scholar 

  19. Scheithauer BW (2009) Development of the WHO classification of tumors of the central nervous system: a historical perspective. Brain Pathol 19:551–564

    Article  PubMed  Google Scholar 

  20. Taylor MD, Northcott PA, Korshunov A et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123:465–472

    Article  CAS  PubMed  Google Scholar 

  21. Yan H, Parsons DW, Jin G (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Zülch KJ, Avtsyn AP, Barnar RO et al (1979) Histological typing of tumors of the central nervous system. World Health Organization, Geneva

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. J. Schulz-Schaeffer.

Ethics declarations

Interessenkonflikt

W. J. Schulz-Schaeffer gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schulz-Schaeffer, W.J. Neuerungen der WHO‑Klassifikation der Hirntumore von 2016. Radiologe 57, 701–706 (2017). https://doi.org/10.1007/s00117-017-0290-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00117-017-0290-3

Schlüsselwörter

Keywords

Navigation